-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
ntenteditable="false" style="border-top:1px dashed rgb(255, 0, 0); color:rgb(255, 255, 255); display:block; font-size:0px; height:0px; left:20px; line-height:0px; margin:0px; padding:0px; position:absolute; top:165px; user-select:none; width:703px; z-index:9999">ntenteditable="false" style="-webkit-border-radius:2px; background:url( center no-repeat #ff0000; border-radius:2px; color:#fff; cursor:pointer; display:block; font-size:0px; height:17px; line-height:0px; margin:0px; padding:0px; position:absolute; right:17px; top:-8px; width:17px; z-index:9999" title="Insert paragraph here">↵ On January 11, Huang Guo, Deputy Director of the State Food and Drug Administration, led a team to Sinopharm China Biotechnology Co.
, Ltd.
to investigate the progress of the research and development of
new crown vaccines and related drugs.
Huang Guo stressed that China's epidemic prevention and control has entered a new stage, the research and development of new crown vaccine drugs should be accelerated, and the quality and safety assurance work should not be relaxed, and the State Food and Drug Administration will continue to maintain a wartime state, with the attitude of starting from scratch and starting again, coordinating supervision and services, and fully serving "health protection" and "prevention of severe disease"
.
Huang Guo and his entourage had an in-depth understanding of the company's new crown vaccine informatization traceability, learned about the progress of the research and development of new crown virus multivalent vaccine and related drugs, discussed the problems and difficulties they faced, and gave guidance
.
Huang Guo pointed out that vaccines and drugs provide a basic guarantee for epidemic prevention and control, and the State Food and Drug Administration will carefully and consistently serve to ensure the overall situation of epidemic prevention and control, adopt the method of early intervention, research and review linkage, and scientifically and rigorously promote the development and marketing of relevant vaccine drugs in accordance with laws and regulations
.
Enterprises should focus on the needs of epidemic prevention and control, further optimize R&D strategies, carry out research in a scientific and standardized manner, increase R&D research efforts, and improve key technology levels
.
At the same time, it is necessary to improve the accessibility of drugs and meet the needs
of the people.
Relevant responsible comrades of the Drug Registration Department of the State Food and Drug Administration and the Drug Review Center participated in the investigation
.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body). 
